Eric R. Olson
2020
In 2020, Eric R. Olson earned a total compensation of $1.2M as Chief Scientific Officer at Syros Pharmaceuticals, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $238,680 |
|---|---|
| Option Awards | $480,697 |
| Salary | $457,385 |
| Other | $360 |
| Total | $1,177,122 |
Olson received $480.7K in option awards, accounting for 41% of the total pay in 2020.
Olson also received $238.7K in non-equity incentive plan, $457.4K in salary and $360 in other compensation.
Rankings
In 2020, Eric R. Olson's compensation ranked 7,925th out of 13,090 executives tracked by ExecPay. In other words, Olson earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,925 out of 13,090 | 40th |
Division Manufacturing | 3,364 out of 5,624 | 40th |
Major group Chemicals And Allied Products | 1,360 out of 2,257 | 40th |
Industry group Drugs | 1,182 out of 1,957 | 40th |
Industry Pharmaceutical Preparations | 880 out of 1,462 | 40th |
Source: SEC filing on April 29, 2021.
Olson's colleagues
We found two more compensation records of executives who worked with Eric R. Olson at Syros Pharmaceuticals in 2020.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019